In this episode of Biotech Leaders on OncoDaily, Shushan Hovsepyan speaks with Chris Burns, CEO of Amplia Therapeutics, to explore his journey in the biotech world, from his early days in drug discovery to his leadership in advancing innovative treatments for cancer and fibrotic diseases. Chris shares his unique perspective on how research integrity, patient outcomes, and strategic vision align to shape the future of oncology.
Key highlights:
???? Chris's path from Pfizer to leading Amplia Therapeutics.
???? How drug discovery background influences leadership in biotech.
???? The rewarding impact of their drug, Narmafotinib, in pancreatic cancer treatment.
???? The mission of Amplia to address unmet needs in oncology and fibrotic diseases.
???? Insightful personal leadership experiences, including tough decisions and core values.
???? Chris’s recommended books that shaped his career and philosophy.
#Biotech #cancer #oncology #PancreaticCancer #AmpliaTherapeutics #InnovationInCancerTreatment #BiotechInsights #cancerresearch #precisionmedicine
0:00 Introduction
00:40 Career journey: From PhD in chemistry to Pfizer, academia, and biotech leadership
02:08 How a scientific background shapes strategic leadership in oncology
03:17 Overview of Amplia’s lead drug, Narmafotinib, and its clinical development
05:08 The potential of FAK inhibition in combination with chemo and immunotherapy
07:02 Targeting pancreatic and ovarian cancers through tumor microenvironment remodeling
09:22 Plans for clinical expansion, partnerships, and future directions
11:06 A message of hope to patients, caregivers, and the oncology community
SUBSCRIBE to get the latest #oncodaily https://www.youtube.com/@OncoDailyTV
Visit the OncoDaily Website : https://oncodaily.com
Like OncoDaily on LinkedIn: https://linkedin.com/company/oncodaily
Like OncoDaily on X (Twitter): https://x.com/oncodaily
Follow OncoDaily on Instagram: https://www.instagram.com/oncodailynews/
Follow OncoDaily on TikTok: https://www.tiktok.com/@oncodaily
Like OncoDaily on Facebook: https://www.facebook.com/oncodaily/
SUBSCRIBE to OncoDaily Newsletter: https://oncodaily.com/submit-newsletter
About OncoDaily
OncoDaily is a world-leading oncology media platform, which is based in the United States and features the cancer related latest news, insights, and patient stories from around the globe. The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”
Key highlights:
???? Chris's path from Pfizer to leading Amplia Therapeutics.
???? How drug discovery background influences leadership in biotech.
???? The rewarding impact of their drug, Narmafotinib, in pancreatic cancer treatment.
???? The mission of Amplia to address unmet needs in oncology and fibrotic diseases.
???? Insightful personal leadership experiences, including tough decisions and core values.
???? Chris’s recommended books that shaped his career and philosophy.
#Biotech #cancer #oncology #PancreaticCancer #AmpliaTherapeutics #InnovationInCancerTreatment #BiotechInsights #cancerresearch #precisionmedicine
0:00 Introduction
00:40 Career journey: From PhD in chemistry to Pfizer, academia, and biotech leadership
02:08 How a scientific background shapes strategic leadership in oncology
03:17 Overview of Amplia’s lead drug, Narmafotinib, and its clinical development
05:08 The potential of FAK inhibition in combination with chemo and immunotherapy
07:02 Targeting pancreatic and ovarian cancers through tumor microenvironment remodeling
09:22 Plans for clinical expansion, partnerships, and future directions
11:06 A message of hope to patients, caregivers, and the oncology community
SUBSCRIBE to get the latest #oncodaily https://www.youtube.com/@OncoDailyTV
Visit the OncoDaily Website : https://oncodaily.com
Like OncoDaily on LinkedIn: https://linkedin.com/company/oncodaily
Like OncoDaily on X (Twitter): https://x.com/oncodaily
Follow OncoDaily on Instagram: https://www.instagram.com/oncodailynews/
Follow OncoDaily on TikTok: https://www.tiktok.com/@oncodaily
Like OncoDaily on Facebook: https://www.facebook.com/oncodaily/
SUBSCRIBE to OncoDaily Newsletter: https://oncodaily.com/submit-newsletter
About OncoDaily
OncoDaily is a world-leading oncology media platform, which is based in the United States and features the cancer related latest news, insights, and patient stories from around the globe. The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”
- Category
- Oncology

Be the first to comment